Search research articles
Contact Us
Filters
Showing results (91-100 of 186) with videos related to
Page
of 19
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 15, 2024
Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma
Sujana Movva, Kenneth Seier, Viswatej Avutu, et al.
JCO Precision Oncology
|
December 22, 2025
CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (<i>NRG1</i>) Fusions
Tejas Patil, Jessica J Lin, Parneet K Cheema, et al.
Nature Medicine
|
August 14, 2019
Resistance to TRK inhibition mediated by convergent MAPK pathway activation
Emiliano Cocco, Alison M Schram, Amanda Kulick, et al.
The New England Journal of Medicine
|
February 5, 2025
Efficacy of Zenocutuzumab in <i>NRG1</i> Fusion-Positive Cancer
Alison M Schram, Koichi Goto, Dong-Wan Kim, et al.
Cancer Discovery
|
October 2, 2020
TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors
Emiliano Cocco, Ji Eun Lee, Srinivasaraghavan Kannan, et al.
Cancer Discovery
|
June 4, 2023
RLY-4008, the First Highly Selective FGFR2 Inhibitor with Activity across FGFR2 Alterations and Resistance Mutations
Vivek Subbiah, Vaibhav Sahai, Dejan Maglic, et al.
Cancer Discovery
|
February 13, 2025
Restoration of the Tumor Suppressor Function of Y220C-Mutant p53 by Rezatapopt, a Small-Molecule Reactivator
Anna M Puzio-Kuter, Lizhong Xu, Mary Kate McBrayer, et al.
Cancer Discovery
|
December 17, 2017
Accelerating Discovery of Functional Mutant Alleles in Cancer
Matthew T Chang, Tripti Shrestha Bhattarai, Alison M Schram, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 2, 2021
Clinicopathologic Features and Response to Therapy of <i>NRG1</i> Fusion-Driven Lung Cancers: The eNRGy1 Global Multicenter Registry
Alexander Drilon, Michael Duruisseaux, Ji-Youn Han, et al.
Cancer Discovery
|
June 5, 2017
A Next-Generation TRK Kinase Inhibitor Overcomes Acquired Resistance to Prior TRK Kinase Inhibition in Patients with TRK Fusion-Positive Solid Tumors
Alexander Drilon, Ramamoorthy Nagasubramanian, James F Blake, et al.
Page
of 19
Search research articles
Search
Showing results (91-100 of 186) with videos related to
Sort By:
Page
of 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 15, 2024
Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma
Sujana Movva, Kenneth Seier, Viswatej Avutu, et al.
JCO Precision Oncology
|
December 22, 2025
CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (<i>NRG1</i>) Fusions
Tejas Patil, Jessica J Lin, Parneet K Cheema, et al.
Nature Medicine
|
August 14, 2019
Resistance to TRK inhibition mediated by convergent MAPK pathway activation
Emiliano Cocco, Alison M Schram, Amanda Kulick, et al.
The New England Journal of Medicine
|
February 5, 2025
Efficacy of Zenocutuzumab in <i>NRG1</i> Fusion-Positive Cancer
Alison M Schram, Koichi Goto, Dong-Wan Kim, et al.
Cancer Discovery
|
October 2, 2020
TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors
Emiliano Cocco, Ji Eun Lee, Srinivasaraghavan Kannan, et al.
Cancer Discovery
|
June 4, 2023
RLY-4008, the First Highly Selective FGFR2 Inhibitor with Activity across FGFR2 Alterations and Resistance Mutations
Vivek Subbiah, Vaibhav Sahai, Dejan Maglic, et al.
Cancer Discovery
|
February 13, 2025
Restoration of the Tumor Suppressor Function of Y220C-Mutant p53 by Rezatapopt, a Small-Molecule Reactivator
Anna M Puzio-Kuter, Lizhong Xu, Mary Kate McBrayer, et al.
Cancer Discovery
|
December 17, 2017
Accelerating Discovery of Functional Mutant Alleles in Cancer
Matthew T Chang, Tripti Shrestha Bhattarai, Alison M Schram, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 2, 2021
Clinicopathologic Features and Response to Therapy of <i>NRG1</i> Fusion-Driven Lung Cancers: The eNRGy1 Global Multicenter Registry
Alexander Drilon, Michael Duruisseaux, Ji-Youn Han, et al.
Cancer Discovery
|
June 5, 2017
A Next-Generation TRK Kinase Inhibitor Overcomes Acquired Resistance to Prior TRK Kinase Inhibition in Patients with TRK Fusion-Positive Solid Tumors
Alexander Drilon, Ramamoorthy Nagasubramanian, James F Blake, et al.
Page
of 19